Skip to main content
Official EU label nameGlossary entry 26641

SODIUM GUANOSINE CYCLIC MONOPHOSPHATE

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence
Markets checked
13
Markets with evidence
0
Evidence gaps
13
Resolved identifiers
2

Resolved substance identity

CAS:40732-48-7
EC:255-056-0
Ingredient index records:
SODIUM GUANOSINE CYCLIC MONOPHOSPHATE
Cosmetic functions: SKIN CONDITIONING

Guanosine, cyclic 3'-5'-(hydrogen phosphate), monosodium salt

1 matched or reported name
SODIUM GUANOSINE CYCLIC MONOPHOSPHATE

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name SODIUM GUANOSINE CYCLIC MONOPHOSPHATE.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Chemical identity and properties

PubChem 2D chemical structure for CAS 40732-48-7
CAS 40732-48-7PubChem CID 135445730

Sodium guanosine cyclic monophosphate

IUPAC name
sodium 9-[(4aR,6R,7R,7aS)-7-hydroxy-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-amino-1H-purin-6-one
Molecular formula
C10H11N5NaO7P
Molecular weight
367.19 g/mol
Exact mass
367.02937899 Da
Topological polar surface area
173.0 Ų
Hydrogen-bond donors
3
Hydrogen-bond acceptors
9
Covalent units
2
Defined stereocentres
4

Also known as

6WYT1TNR45Guanosine, cyclic 3',5'-(hydrogen phosphate), monosodium saltRefChem:1098798255-056-0Guanosine 3',5'-cyclic monophosphate sodium saltGuanosine Monophosphate Monosodium SaltGuanosine-3':5'-cyclic monophosphate monosodium saltMonosodium-GMP
16 more reported names
GUANOSINE3:5-CYCLICMONOPHOSPHATESODIUMSALTSodium (4aR,6R,7R,7aS)-6-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxideCyclic GMP (sodium)sodium;9-[(4aR,6R,7R,7aS)-7-hydroxy-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-amino-1H-purin-6-onesodium;9-[(4aR,6R,7R,7aS)-7-hydroxy-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-amino-3H-purin-6-oneUNII-6WYT1TNR45Cyclic GMP sodiumEINECS 255-056-0Cyclic 3',5'-Guanosine Monophosphate Monosodium SaltCYCLIC GMP, SODIUM SALTEBC-616924AS-71285guanosine 3',5'-cyclic-monophosphate sodium saltGUANOSINE 3, 5'-MONOPHOSPHATE, SODIUM SALTGuanosine 3',5'-cyclic monophosphate sodium salt (cGMP)Guanosine 3',5'-cyclic monophosphate sodium salt, >=99% (HPLC), powder
External database identifiers

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Take this record further

Screen in a formulaOpen standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision